nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—Metoclopramide—DRD3—Gilles de la Tourette syndrome	0.0135	0.591	CrCbGaD
Sunitinib—Metoclopramide—DRD2—Gilles de la Tourette syndrome	0.00937	0.409	CrCbGaD
Sunitinib—CSNK2A1—nervous system—Gilles de la Tourette syndrome	0.00267	0.00321	CbGeAlD
Sunitinib—PRPF4B—central nervous system—Gilles de la Tourette syndrome	0.00264	0.00317	CbGeAlD
Sunitinib—MYLK—nervous system—Gilles de la Tourette syndrome	0.00263	0.00317	CbGeAlD
Sunitinib—CLK4—brain—Gilles de la Tourette syndrome	0.0026	0.00314	CbGeAlD
Sunitinib—STK39—central nervous system—Gilles de la Tourette syndrome	0.0026	0.00313	CbGeAlD
Sunitinib—STK4—nervous system—Gilles de la Tourette syndrome	0.00258	0.00311	CbGeAlD
Sunitinib—SBK1—brain—Gilles de la Tourette syndrome	0.00257	0.0031	CbGeAlD
Sunitinib—CSNK2A1—central nervous system—Gilles de la Tourette syndrome	0.00257	0.00309	CbGeAlD
Sunitinib—MAP4K4—midbrain—Gilles de la Tourette syndrome	0.00256	0.00308	CbGeAlD
Sunitinib—HIPK4—brain—Gilles de la Tourette syndrome	0.00254	0.00306	CbGeAlD
Sunitinib—PHKG2—nervous system—Gilles de la Tourette syndrome	0.00254	0.00305	CbGeAlD
Sunitinib—MYLK—central nervous system—Gilles de la Tourette syndrome	0.00253	0.00305	CbGeAlD
Sunitinib—MAP3K12—midbrain—Gilles de la Tourette syndrome	0.00252	0.00304	CbGeAlD
Sunitinib—STK24—nervous system—Gilles de la Tourette syndrome	0.00252	0.00304	CbGeAlD
Sunitinib—DAPK1—brain—Gilles de la Tourette syndrome	0.00252	0.00303	CbGeAlD
Sunitinib—PHKG1—brain—Gilles de la Tourette syndrome	0.00252	0.00303	CbGeAlD
Sunitinib—RPS6KA3—midbrain—Gilles de la Tourette syndrome	0.00249	0.003	CbGeAlD
Sunitinib—STK4—central nervous system—Gilles de la Tourette syndrome	0.00249	0.00299	CbGeAlD
Sunitinib—STK16—nervous system—Gilles de la Tourette syndrome	0.00245	0.00295	CbGeAlD
Sunitinib—PHKG2—central nervous system—Gilles de la Tourette syndrome	0.00244	0.00294	CbGeAlD
Sunitinib—CSNK1A1—midbrain—Gilles de la Tourette syndrome	0.00244	0.00294	CbGeAlD
Sunitinib—HIPK2—nervous system—Gilles de la Tourette syndrome	0.00244	0.00294	CbGeAlD
Sunitinib—TYRO3—nervous system—Gilles de la Tourette syndrome	0.00244	0.00294	CbGeAlD
Sunitinib—ALK—nervous system—Gilles de la Tourette syndrome	0.00244	0.00294	CbGeAlD
Sunitinib—BRD4—brain—Gilles de la Tourette syndrome	0.00244	0.00293	CbGeAlD
Sunitinib—STK11—brain—Gilles de la Tourette syndrome	0.00244	0.00293	CbGeAlD
Sunitinib—STK24—central nervous system—Gilles de la Tourette syndrome	0.00243	0.00292	CbGeAlD
Sunitinib—CLK1—midbrain—Gilles de la Tourette syndrome	0.00243	0.00292	CbGeAlD
Sunitinib—RIOK2—nervous system—Gilles de la Tourette syndrome	0.00242	0.00291	CbGeAlD
Sunitinib—RIOK1—brain—Gilles de la Tourette syndrome	0.00241	0.0029	CbGeAlD
Sunitinib—RPS6KA1—brain—Gilles de la Tourette syndrome	0.00241	0.0029	CbGeAlD
Sunitinib—MAP3K19—nervous system—Gilles de la Tourette syndrome	0.00239	0.00288	CbGeAlD
Sunitinib—CAMK2G—midbrain—Gilles de la Tourette syndrome	0.00238	0.00287	CbGeAlD
Sunitinib—BMP2K—midbrain—Gilles de la Tourette syndrome	0.00238	0.00287	CbGeAlD
Sunitinib—TNIK—brain—Gilles de la Tourette syndrome	0.00237	0.00285	CbGeAlD
Sunitinib—MARK2—brain—Gilles de la Tourette syndrome	0.00237	0.00285	CbGeAlD
Sunitinib—STK16—central nervous system—Gilles de la Tourette syndrome	0.00236	0.00284	CbGeAlD
Sunitinib—LRRK2—midbrain—Gilles de la Tourette syndrome	0.00236	0.00284	CbGeAlD
Sunitinib—HIPK2—central nervous system—Gilles de la Tourette syndrome	0.00235	0.00283	CbGeAlD
Sunitinib—ALK—central nervous system—Gilles de la Tourette syndrome	0.00235	0.00283	CbGeAlD
Sunitinib—TYRO3—central nervous system—Gilles de la Tourette syndrome	0.00235	0.00283	CbGeAlD
Sunitinib—DAPK3—nervous system—Gilles de la Tourette syndrome	0.00235	0.00282	CbGeAlD
Sunitinib—SGK3—brain—Gilles de la Tourette syndrome	0.00234	0.00282	CbGeAlD
Sunitinib—RIOK2—central nervous system—Gilles de la Tourette syndrome	0.00233	0.0028	CbGeAlD
Sunitinib—CLK2—nervous system—Gilles de la Tourette syndrome	0.00232	0.0028	CbGeAlD
Sunitinib—ICK—brain—Gilles de la Tourette syndrome	0.00232	0.00279	CbGeAlD
Sunitinib—MAP3K19—central nervous system—Gilles de la Tourette syndrome	0.0023	0.00277	CbGeAlD
Sunitinib—CSNK1E—midbrain—Gilles de la Tourette syndrome	0.00226	0.00272	CbGeAlD
Sunitinib—FGFR1—midbrain—Gilles de la Tourette syndrome	0.00226	0.00272	CbGeAlD
Sunitinib—DAPK3—central nervous system—Gilles de la Tourette syndrome	0.00226	0.00272	CbGeAlD
Sunitinib—ROCK1—nervous system—Gilles de la Tourette syndrome	0.00225	0.00271	CbGeAlD
Sunitinib—CHEK2—brain—Gilles de la Tourette syndrome	0.00224	0.0027	CbGeAlD
Sunitinib—NUAK1—brain—Gilles de la Tourette syndrome	0.00224	0.0027	CbGeAlD
Sunitinib—CLK2—central nervous system—Gilles de la Tourette syndrome	0.00224	0.00269	CbGeAlD
Sunitinib—SNRK—brain—Gilles de la Tourette syndrome	0.00222	0.00268	CbGeAlD
Sunitinib—OXSR1—brain—Gilles de la Tourette syndrome	0.00222	0.00268	CbGeAlD
Sunitinib—INSR—brain—Gilles de la Tourette syndrome	0.00222	0.00268	CbGeAlD
Sunitinib—DYRK1A—nervous system—Gilles de la Tourette syndrome	0.0022	0.00264	CbGeAlD
Sunitinib—STK38—brain—Gilles de la Tourette syndrome	0.00219	0.00263	CbGeAlD
Sunitinib—RPS6KA2—brain—Gilles de la Tourette syndrome	0.00219	0.00263	CbGeAlD
Sunitinib—MAP2K2—midbrain—Gilles de la Tourette syndrome	0.00218	0.00262	CbGeAlD
Sunitinib—ULK3—midbrain—Gilles de la Tourette syndrome	0.00218	0.00262	CbGeAlD
Sunitinib—AURKC—brain—Gilles de la Tourette syndrome	0.00217	0.00261	CbGeAlD
Sunitinib—ROCK1—central nervous system—Gilles de la Tourette syndrome	0.00217	0.00261	CbGeAlD
Sunitinib—CSNK1G2—brain—Gilles de la Tourette syndrome	0.00216	0.00259	CbGeAlD
Sunitinib—PKN1—brain—Gilles de la Tourette syndrome	0.00216	0.00259	CbGeAlD
Sunitinib—MERTK—nervous system—Gilles de la Tourette syndrome	0.00214	0.00258	CbGeAlD
Sunitinib—MAP3K7—midbrain—Gilles de la Tourette syndrome	0.00214	0.00258	CbGeAlD
Sunitinib—PRPF4—brain—Gilles de la Tourette syndrome	0.00212	0.00256	CbGeAlD
Sunitinib—TBK1—midbrain—Gilles de la Tourette syndrome	0.00212	0.00255	CbGeAlD
Sunitinib—DYRK1A—central nervous system—Gilles de la Tourette syndrome	0.00211	0.00254	CbGeAlD
Sunitinib—MAP4K4—nervous system—Gilles de la Tourette syndrome	0.00211	0.00253	CbGeAlD
Sunitinib—TYK2—midbrain—Gilles de la Tourette syndrome	0.0021	0.00253	CbGeAlD
Sunitinib—PRPF4B—brain—Gilles de la Tourette syndrome	0.00209	0.00252	CbGeAlD
Sunitinib—IRAK1—midbrain—Gilles de la Tourette syndrome	0.00208	0.0025	CbGeAlD
Sunitinib—MAP3K12—nervous system—Gilles de la Tourette syndrome	0.00208	0.0025	CbGeAlD
Sunitinib—MERTK—central nervous system—Gilles de la Tourette syndrome	0.00206	0.00249	CbGeAlD
Sunitinib—STK39—brain—Gilles de la Tourette syndrome	0.00206	0.00249	CbGeAlD
Sunitinib—RPS6KA3—nervous system—Gilles de la Tourette syndrome	0.00205	0.00246	CbGeAlD
Sunitinib—CSNK2A1—brain—Gilles de la Tourette syndrome	0.00204	0.00245	CbGeAlD
Sunitinib—RPS6KB1—midbrain—Gilles de la Tourette syndrome	0.00204	0.00245	CbGeAlD
Sunitinib—MAP2K1—nervous system—Gilles de la Tourette syndrome	0.00203	0.00245	CbGeAlD
Sunitinib—MAP4K4—central nervous system—Gilles de la Tourette syndrome	0.00203	0.00244	CbGeAlD
Sunitinib—RET—midbrain—Gilles de la Tourette syndrome	0.00202	0.00244	CbGeAlD
Sunitinib—AXL—midbrain—Gilles de la Tourette syndrome	0.00202	0.00243	CbGeAlD
Sunitinib—MYLK—brain—Gilles de la Tourette syndrome	0.00201	0.00242	CbGeAlD
Sunitinib—CSNK1A1—nervous system—Gilles de la Tourette syndrome	0.00201	0.00242	CbGeAlD
Sunitinib—MAP3K12—central nervous system—Gilles de la Tourette syndrome	0.002	0.00241	CbGeAlD
Sunitinib—CLK1—nervous system—Gilles de la Tourette syndrome	0.00199	0.0024	CbGeAlD
Sunitinib—PLK4—brain—Gilles de la Tourette syndrome	0.00199	0.00239	CbGeAlD
Sunitinib—STK4—brain—Gilles de la Tourette syndrome	0.00197	0.00238	CbGeAlD
Sunitinib—RPS6KA3—central nervous system—Gilles de la Tourette syndrome	0.00197	0.00237	CbGeAlD
Sunitinib—MAP2K1—central nervous system—Gilles de la Tourette syndrome	0.00196	0.00236	CbGeAlD
Sunitinib—CAMK2G—nervous system—Gilles de la Tourette syndrome	0.00196	0.00236	CbGeAlD
Sunitinib—BMP2K—nervous system—Gilles de la Tourette syndrome	0.00196	0.00236	CbGeAlD
Sunitinib—SLK—midbrain—Gilles de la Tourette syndrome	0.00194	0.00234	CbGeAlD
Sunitinib—LRRK2—nervous system—Gilles de la Tourette syndrome	0.00194	0.00233	CbGeAlD
Sunitinib—PHKG2—brain—Gilles de la Tourette syndrome	0.00194	0.00233	CbGeAlD
Sunitinib—CSNK1A1—central nervous system—Gilles de la Tourette syndrome	0.00193	0.00233	CbGeAlD
Sunitinib—STK24—brain—Gilles de la Tourette syndrome	0.00193	0.00232	CbGeAlD
Sunitinib—CLK1—central nervous system—Gilles de la Tourette syndrome	0.00192	0.00231	CbGeAlD
Sunitinib—PRKAA1—nervous system—Gilles de la Tourette syndrome	0.00191	0.0023	CbGeAlD
Sunitinib—DAPK2—brain—Gilles de la Tourette syndrome	0.00191	0.00229	CbGeAlD
Sunitinib—PTK2B—nervous system—Gilles de la Tourette syndrome	0.00189	0.00228	CbGeAlD
Sunitinib—FYN—midbrain—Gilles de la Tourette syndrome	0.00189	0.00227	CbGeAlD
Sunitinib—CAMK2G—central nervous system—Gilles de la Tourette syndrome	0.00188	0.00227	CbGeAlD
Sunitinib—BMP2K—central nervous system—Gilles de la Tourette syndrome	0.00188	0.00227	CbGeAlD
Sunitinib—STK16—brain—Gilles de la Tourette syndrome	0.00188	0.00226	CbGeAlD
Sunitinib—LRRK2—central nervous system—Gilles de la Tourette syndrome	0.00187	0.00225	CbGeAlD
Sunitinib—HIPK2—brain—Gilles de la Tourette syndrome	0.00187	0.00225	CbGeAlD
Sunitinib—HIPK3—brain—Gilles de la Tourette syndrome	0.00187	0.00225	CbGeAlD
Sunitinib—TYRO3—brain—Gilles de la Tourette syndrome	0.00187	0.00225	CbGeAlD
Sunitinib—ALK—brain—Gilles de la Tourette syndrome	0.00187	0.00225	CbGeAlD
Sunitinib—CSNK1E—nervous system—Gilles de la Tourette syndrome	0.00186	0.00224	CbGeAlD
Sunitinib—TNK1—brain—Gilles de la Tourette syndrome	0.00185	0.00222	CbGeAlD
Sunitinib—RIOK2—brain—Gilles de la Tourette syndrome	0.00185	0.00222	CbGeAlD
Sunitinib—MAP3K3—midbrain—Gilles de la Tourette syndrome	0.00184	0.00222	CbGeAlD
Sunitinib—MAP4K5—midbrain—Gilles de la Tourette syndrome	0.00184	0.00222	CbGeAlD
Sunitinib—PRKAA1—central nervous system—Gilles de la Tourette syndrome	0.00184	0.00222	CbGeAlD
Sunitinib—IRAK4—nervous system—Gilles de la Tourette syndrome	0.00183	0.0022	CbGeAlD
Sunitinib—MAP3K19—brain—Gilles de la Tourette syndrome	0.00183	0.0022	CbGeAlD
Sunitinib—MAP4K1—brain—Gilles de la Tourette syndrome	0.00183	0.0022	CbGeAlD
Sunitinib—PTK2B—central nervous system—Gilles de la Tourette syndrome	0.00182	0.00219	CbGeAlD
Sunitinib—DAPK3—brain—Gilles de la Tourette syndrome	0.00179	0.00216	CbGeAlD
Sunitinib—CSNK1E—central nervous system—Gilles de la Tourette syndrome	0.00179	0.00216	CbGeAlD
Sunitinib—ULK3—nervous system—Gilles de la Tourette syndrome	0.00179	0.00215	CbGeAlD
Sunitinib—MAP2K2—nervous system—Gilles de la Tourette syndrome	0.00179	0.00215	CbGeAlD
Sunitinib—FLT1—midbrain—Gilles de la Tourette syndrome	0.00178	0.00215	CbGeAlD
Sunitinib—MAP3K2—nervous system—Gilles de la Tourette syndrome	0.00178	0.00214	CbGeAlD
Sunitinib—CLK2—brain—Gilles de la Tourette syndrome	0.00178	0.00214	CbGeAlD
Sunitinib—MAP4K2—brain—Gilles de la Tourette syndrome	0.00177	0.00213	CbGeAlD
Sunitinib—IRAK4—central nervous system—Gilles de la Tourette syndrome	0.00176	0.00212	CbGeAlD
Sunitinib—EPHB6—midbrain—Gilles de la Tourette syndrome	0.00176	0.00212	CbGeAlD
Sunitinib—STK3—brain—Gilles de la Tourette syndrome	0.00174	0.0021	CbGeAlD
Sunitinib—TBK1—nervous system—Gilles de la Tourette syndrome	0.00174	0.0021	CbGeAlD
Sunitinib—TYK2—nervous system—Gilles de la Tourette syndrome	0.00173	0.00208	CbGeAlD
Sunitinib—MAP2K2—central nervous system—Gilles de la Tourette syndrome	0.00172	0.00207	CbGeAlD
Sunitinib—ULK3—central nervous system—Gilles de la Tourette syndrome	0.00172	0.00207	CbGeAlD
Sunitinib—ROCK1—brain—Gilles de la Tourette syndrome	0.00172	0.00207	CbGeAlD
Sunitinib—MAP3K2—central nervous system—Gilles de la Tourette syndrome	0.00171	0.00206	CbGeAlD
Sunitinib—YES1—midbrain—Gilles de la Tourette syndrome	0.0017	0.00205	CbGeAlD
Sunitinib—TAOK3—midbrain—Gilles de la Tourette syndrome	0.00168	0.00202	CbGeAlD
Sunitinib—DYRK1A—brain—Gilles de la Tourette syndrome	0.00168	0.00202	CbGeAlD
Sunitinib—TBK1—central nervous system—Gilles de la Tourette syndrome	0.00168	0.00202	CbGeAlD
Sunitinib—RPS6KB1—nervous system—Gilles de la Tourette syndrome	0.00167	0.00202	CbGeAlD
Sunitinib—TYK2—central nervous system—Gilles de la Tourette syndrome	0.00166	0.002	CbGeAlD
Sunitinib—RET—nervous system—Gilles de la Tourette syndrome	0.00166	0.002	CbGeAlD
Sunitinib—FGR—nervous system—Gilles de la Tourette syndrome	0.00166	0.002	CbGeAlD
Sunitinib—AXL—nervous system—Gilles de la Tourette syndrome	0.00166	0.002	CbGeAlD
Sunitinib—MERTK—brain—Gilles de la Tourette syndrome	0.00164	0.00197	CbGeAlD
Sunitinib—RPS6KB1—central nervous system—Gilles de la Tourette syndrome	0.00161	0.00194	CbGeAlD
Sunitinib—MAP4K4—brain—Gilles de la Tourette syndrome	0.00161	0.00194	CbGeAlD
Sunitinib—FGR—central nervous system—Gilles de la Tourette syndrome	0.0016	0.00193	CbGeAlD
Sunitinib—RET—central nervous system—Gilles de la Tourette syndrome	0.0016	0.00193	CbGeAlD
Sunitinib—NUAK2—brain—Gilles de la Tourette syndrome	0.0016	0.00192	CbGeAlD
Sunitinib—AXL—central nervous system—Gilles de la Tourette syndrome	0.0016	0.00192	CbGeAlD
Sunitinib—MAP3K12—brain—Gilles de la Tourette syndrome	0.00159	0.00191	CbGeAlD
Sunitinib—FGFR2—nervous system—Gilles de la Tourette syndrome	0.00158	0.0019	CbGeAlD
Sunitinib—JAK2—nervous system—Gilles de la Tourette syndrome	0.00157	0.00189	CbGeAlD
Sunitinib—RPS6KA3—brain—Gilles de la Tourette syndrome	0.00156	0.00188	CbGeAlD
Sunitinib—MAP2K1—brain—Gilles de la Tourette syndrome	0.00155	0.00187	CbGeAlD
Sunitinib—FYN—nervous system—Gilles de la Tourette syndrome	0.00155	0.00187	CbGeAlD
Sunitinib—CSNK1A1—brain—Gilles de la Tourette syndrome	0.00153	0.00185	CbGeAlD
Sunitinib—CLK1—brain—Gilles de la Tourette syndrome	0.00152	0.00183	CbGeAlD
Sunitinib—FGFR2—central nervous system—Gilles de la Tourette syndrome	0.00152	0.00183	CbGeAlD
Sunitinib—MAP4K5—nervous system—Gilles de la Tourette syndrome	0.00152	0.00182	CbGeAlD
Sunitinib—MAP3K3—nervous system—Gilles de la Tourette syndrome	0.00152	0.00182	CbGeAlD
Sunitinib—JAK2—central nervous system—Gilles de la Tourette syndrome	0.00151	0.00182	CbGeAlD
Sunitinib—KDR—midbrain—Gilles de la Tourette syndrome	0.00151	0.00181	CbGeAlD
Sunitinib—MAP2K5—midbrain—Gilles de la Tourette syndrome	0.00151	0.00181	CbGeAlD
Sunitinib—BMP2K—brain—Gilles de la Tourette syndrome	0.0015	0.0018	CbGeAlD
Sunitinib—CAMK2G—brain—Gilles de la Tourette syndrome	0.0015	0.0018	CbGeAlD
Sunitinib—FYN—central nervous system—Gilles de la Tourette syndrome	0.00149	0.0018	CbGeAlD
Sunitinib—LRRK2—brain—Gilles de la Tourette syndrome	0.00148	0.00178	CbGeAlD
Sunitinib—CSF1R—midbrain—Gilles de la Tourette syndrome	0.00147	0.00177	CbGeAlD
Sunitinib—FLT1—nervous system—Gilles de la Tourette syndrome	0.00147	0.00176	CbGeAlD
Sunitinib—PRKAA1—brain—Gilles de la Tourette syndrome	0.00146	0.00176	CbGeAlD
Sunitinib—MAP4K5—central nervous system—Gilles de la Tourette syndrome	0.00146	0.00176	CbGeAlD
Sunitinib—MAP3K3—central nervous system—Gilles de la Tourette syndrome	0.00146	0.00176	CbGeAlD
Sunitinib—EPHB6—nervous system—Gilles de la Tourette syndrome	0.00145	0.00174	CbGeAlD
Sunitinib—PTK2B—brain—Gilles de la Tourette syndrome	0.00144	0.00174	CbGeAlD
Sunitinib—FLT4—brain—Gilles de la Tourette syndrome	0.00144	0.00173	CbGeAlD
Sunitinib—CSNK1E—brain—Gilles de la Tourette syndrome	0.00142	0.00171	CbGeAlD
Sunitinib—FGFR1—brain—Gilles de la Tourette syndrome	0.00142	0.00171	CbGeAlD
Sunitinib—FLT1—central nervous system—Gilles de la Tourette syndrome	0.00141	0.0017	CbGeAlD
Sunitinib—YES1—nervous system—Gilles de la Tourette syndrome	0.0014	0.00169	CbGeAlD
Sunitinib—IRAK4—brain—Gilles de la Tourette syndrome	0.0014	0.00168	CbGeAlD
Sunitinib—EPHB6—central nervous system—Gilles de la Tourette syndrome	0.00139	0.00168	CbGeAlD
Sunitinib—STK10—nervous system—Gilles de la Tourette syndrome	0.00139	0.00167	CbGeAlD
Sunitinib—TAOK3—nervous system—Gilles de la Tourette syndrome	0.00138	0.00166	CbGeAlD
Sunitinib—PDGFRA—nervous system—Gilles de la Tourette syndrome	0.00137	0.00165	CbGeAlD
Sunitinib—ULK3—brain—Gilles de la Tourette syndrome	0.00137	0.00165	CbGeAlD
Sunitinib—MAP2K2—brain—Gilles de la Tourette syndrome	0.00137	0.00165	CbGeAlD
Sunitinib—MAP3K2—brain—Gilles de la Tourette syndrome	0.00136	0.00164	CbGeAlD
Sunitinib—YES1—central nervous system—Gilles de la Tourette syndrome	0.00135	0.00162	CbGeAlD
Sunitinib—MAP3K7—brain—Gilles de la Tourette syndrome	0.00135	0.00162	CbGeAlD
Sunitinib—STK10—central nervous system—Gilles de la Tourette syndrome	0.00134	0.00161	CbGeAlD
Sunitinib—KIT—midbrain—Gilles de la Tourette syndrome	0.00134	0.00161	CbGeAlD
Sunitinib—TAOK3—central nervous system—Gilles de la Tourette syndrome	0.00133	0.0016	CbGeAlD
Sunitinib—TBK1—brain—Gilles de la Tourette syndrome	0.00133	0.0016	CbGeAlD
Sunitinib—PDGFRA—central nervous system—Gilles de la Tourette syndrome	0.00132	0.00159	CbGeAlD
Sunitinib—TYK2—brain—Gilles de la Tourette syndrome	0.00132	0.00159	CbGeAlD
Sunitinib—PDGFRB—midbrain—Gilles de la Tourette syndrome	0.0013	0.00157	CbGeAlD
Sunitinib—IRAK1—brain—Gilles de la Tourette syndrome	0.0013	0.00157	CbGeAlD
Sunitinib—RPS6KB1—brain—Gilles de la Tourette syndrome	0.00128	0.00154	CbGeAlD
Sunitinib—RET—brain—Gilles de la Tourette syndrome	0.00127	0.00153	CbGeAlD
Sunitinib—FGR—brain—Gilles de la Tourette syndrome	0.00127	0.00153	CbGeAlD
Sunitinib—AXL—brain—Gilles de la Tourette syndrome	0.00127	0.00152	CbGeAlD
Sunitinib—MAP2K5—nervous system—Gilles de la Tourette syndrome	0.00124	0.00149	CbGeAlD
Sunitinib—KDR—nervous system—Gilles de la Tourette syndrome	0.00124	0.00149	CbGeAlD
Sunitinib—SLK—brain—Gilles de la Tourette syndrome	0.00122	0.00147	CbGeAlD
Sunitinib—CSF1R—nervous system—Gilles de la Tourette syndrome	0.00121	0.00146	CbGeAlD
Sunitinib—FGFR2—brain—Gilles de la Tourette syndrome	0.00121	0.00145	CbGeAlD
Sunitinib—JAK2—brain—Gilles de la Tourette syndrome	0.0012	0.00145	CbGeAlD
Sunitinib—MAP2K5—central nervous system—Gilles de la Tourette syndrome	0.00119	0.00144	CbGeAlD
Sunitinib—KDR—central nervous system—Gilles de la Tourette syndrome	0.00119	0.00144	CbGeAlD
Sunitinib—FYN—brain—Gilles de la Tourette syndrome	0.00119	0.00143	CbGeAlD
Sunitinib—CSF1R—central nervous system—Gilles de la Tourette syndrome	0.00116	0.0014	CbGeAlD
Sunitinib—MAP4K5—brain—Gilles de la Tourette syndrome	0.00116	0.00139	CbGeAlD
Sunitinib—MAP3K3—brain—Gilles de la Tourette syndrome	0.00116	0.00139	CbGeAlD
Sunitinib—FLT1—brain—Gilles de la Tourette syndrome	0.00112	0.00135	CbGeAlD
Sunitinib—EPHB6—brain—Gilles de la Tourette syndrome	0.00111	0.00133	CbGeAlD
Sunitinib—KIT—nervous system—Gilles de la Tourette syndrome	0.0011	0.00132	CbGeAlD
Sunitinib—PDGFRB—nervous system—Gilles de la Tourette syndrome	0.00107	0.00129	CbGeAlD
Sunitinib—YES1—brain—Gilles de la Tourette syndrome	0.00107	0.00129	CbGeAlD
Sunitinib—STK10—brain—Gilles de la Tourette syndrome	0.00106	0.00128	CbGeAlD
Sunitinib—KIT—central nervous system—Gilles de la Tourette syndrome	0.00106	0.00127	CbGeAlD
Sunitinib—TAOK3—brain—Gilles de la Tourette syndrome	0.00106	0.00127	CbGeAlD
Sunitinib—PDGFRA—brain—Gilles de la Tourette syndrome	0.00105	0.00126	CbGeAlD
Sunitinib—PDGFRB—central nervous system—Gilles de la Tourette syndrome	0.00103	0.00124	CbGeAlD
Sunitinib—KDR—brain—Gilles de la Tourette syndrome	0.000947	0.00114	CbGeAlD
Sunitinib—MAP2K5—brain—Gilles de la Tourette syndrome	0.000947	0.00114	CbGeAlD
Sunitinib—CSF1R—brain—Gilles de la Tourette syndrome	0.000924	0.00111	CbGeAlD
Sunitinib—ABCC4—nervous system—Gilles de la Tourette syndrome	0.000854	0.00103	CbGeAlD
Sunitinib—KIT—brain—Gilles de la Tourette syndrome	0.000839	0.00101	CbGeAlD
Sunitinib—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000824	0.000992	CbGeAlD
Sunitinib—ABCC4—central nervous system—Gilles de la Tourette syndrome	0.000822	0.00099	CbGeAlD
Sunitinib—PDGFRB—brain—Gilles de la Tourette syndrome	0.00082	0.000987	CbGeAlD
Sunitinib—ABCG2—midbrain—Gilles de la Tourette syndrome	0.000733	0.000883	CbGeAlD
Sunitinib—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000678	0.000816	CbGeAlD
Sunitinib—ABCC4—brain—Gilles de la Tourette syndrome	0.000653	0.000786	CbGeAlD
Sunitinib—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000652	0.000785	CbGeAlD
Sunitinib—KCNH2—brain—Gilles de la Tourette syndrome	0.000518	0.000623	CbGeAlD
Sunitinib—ABCG2—brain—Gilles de la Tourette syndrome	0.000461	0.000555	CbGeAlD
Sunitinib—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00042	0.000505	CbGeAlD
Sunitinib—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000404	0.000487	CbGeAlD
Sunitinib—RPS6KA2—Axon guidance—MET—Gilles de la Tourette syndrome	0.000369	0.00253	CbGpPWpGaD
Sunitinib—BLK—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000362	0.00248	CbGpPWpGaD
Sunitinib—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000362	0.000435	CbGeAlD
Sunitinib—FGR—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000361	0.00247	CbGpPWpGaD
Sunitinib—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00036	0.00246	CbGpPWpGaD
Sunitinib—EPHB6—Axon guidance—MET—Gilles de la Tourette syndrome	0.000359	0.00245	CbGpPWpGaD
Sunitinib—ROCK1—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000358	0.00245	CbGpPWpGaD
Sunitinib—MAP3K7—TGF-beta Signaling Pathway—MET—Gilles de la Tourette syndrome	0.000348	0.00238	CbGpPWpGaD
Sunitinib—MAP2K5—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000345	0.00236	CbGpPWpGaD
Sunitinib—KDR—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000336	0.0023	CbGpPWpGaD
Sunitinib—RPS6KA1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000332	0.00227	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000328	0.00224	CbGpPWpGaD
Sunitinib—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000328	0.00224	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000319	0.00218	CbGpPWpGaD
Sunitinib—CSNK2A1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000315	0.00215	CbGpPWpGaD
Sunitinib—PAK3—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000305	0.00209	CbGpPWpGaD
Sunitinib—MAP2K2—TGF-beta Signaling Pathway—MET—Gilles de la Tourette syndrome	0.000305	0.00208	CbGpPWpGaD
Sunitinib—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000297	0.000358	CbGeAlD
Sunitinib—STK4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000297	0.00203	CbGpPWpGaD
Sunitinib—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000286	0.000344	CbGeAlD
Sunitinib—MAP2K1—TGF-beta Signaling Pathway—MET—Gilles de la Tourette syndrome	0.000285	0.00195	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000279	0.00191	CbGpPWpGaD
Sunitinib—LATS2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000274	0.00188	CbGpPWpGaD
Sunitinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000273	0.00187	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000271	0.00185	CbGpPWpGaD
Sunitinib—RPS6KA5—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000266	0.00182	CbGpPWpGaD
Sunitinib—RPS6KA3—Axon guidance—MET—Gilles de la Tourette syndrome	0.000264	0.00181	CbGpPWpGaD
Sunitinib—RPS6KA2—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000264	0.0018	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000263	0.0018	CbGpPWpGaD
Sunitinib—EPHB6—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000256	0.00175	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000255	0.00174	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000253	0.00173	CbGpPWpGaD
Sunitinib—PDGFRA—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000246	0.00168	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000238	0.00163	CbGpPWpGaD
Sunitinib—RPS6KA1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000237	0.00162	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000236	0.00161	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000234	0.0016	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000234	0.0016	CbGpPWpGaD
Sunitinib—ROCK1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000233	0.0016	CbGpPWpGaD
Sunitinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000231	0.00158	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000229	0.00157	CbGpPWpGaD
Sunitinib—MAP2K2—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000228	0.00156	CbGpPWpGaD
Sunitinib—ABCB1—brain—Gilles de la Tourette syndrome	0.000227	0.000273	CbGeAlD
Sunitinib—CSNK1G2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000227	0.00155	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000227	0.00155	CbGpPWpGaD
Sunitinib—PDGFRB—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000222	0.00152	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000222	0.00152	CbGpPWpGaD
Sunitinib—KDR—Axon guidance—MET—Gilles de la Tourette syndrome	0.000219	0.0015	CbGpPWpGaD
Sunitinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000216	0.00148	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000215	0.00147	CbGpPWpGaD
Sunitinib—FYN—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000214	0.00146	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000214	0.00146	CbGpPWpGaD
Sunitinib—MAP2K1—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.000213	0.00146	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000212	0.00145	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000212	0.00145	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000208	0.00142	CbGpPWpGaD
Sunitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000207	0.00141	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000203	0.00139	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000201	0.00137	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000197	0.00135	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000195	0.00134	CbGpPWpGaD
Sunitinib—YES1—Axon guidance—MET—Gilles de la Tourette syndrome	0.00019	0.0013	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00019	0.0013	CbGpPWpGaD
Sunitinib—RPS6KA3—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000189	0.00129	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000188	0.00129	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000186	0.00127	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000186	0.00127	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000183	0.00125	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000183	0.00125	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000183	0.00125	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00018	0.00123	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00018	0.00123	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00018	0.00123	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000178	0.00121	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000177	0.00121	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000177	0.00121	CbGpPWpGaD
Sunitinib—TYK2—Axon guidance—MET—Gilles de la Tourette syndrome	0.000175	0.0012	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000175	0.00119	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00017	0.00116	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000168	0.00115	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000168	0.00115	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000167	0.00114	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000167	0.00114	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000166	0.00114	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000166	0.00114	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000165	0.00113	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000163	0.00111	CbGpPWpGaD
Sunitinib—FGFR1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000161	0.0011	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000161	0.0011	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000161	0.0011	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000157	0.00107	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000156	0.00107	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000155	0.00106	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000152	0.00104	CbGpPWpGaD
Sunitinib—ABCC4—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000152	0.00104	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000151	0.00103	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00015	0.00103	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00015	0.00103	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00015	0.00102	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00015	0.00102	CbGpPWpGaD
Sunitinib—MAP2K2—Axon guidance—MET—Gilles de la Tourette syndrome	0.000148	0.00101	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	0.000148	0.00101	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000148	0.00101	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000148	0.00101	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000148	0.00101	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000144	0.000982	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000142	0.00097	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000141	0.00096	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00014	0.00096	CbGpPWpGaD
Sunitinib—FYN—Axon guidance—MET—Gilles de la Tourette syndrome	0.00014	0.000955	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00014	0.000954	CbGpPWpGaD
Sunitinib—MAP2K1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000139	0.00095	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000138	0.000946	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000136	0.000928	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000135	0.000926	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000134	0.000919	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000134	0.000915	CbGpPWpGaD
Sunitinib—JAK2—Axon guidance—MET—Gilles de la Tourette syndrome	0.000133	0.000908	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000129	0.000878	CbGpPWpGaD
Sunitinib—ABCC2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000128	0.000875	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000126	0.000863	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000125	0.000856	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000125	0.000855	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000125	0.000852	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000124	0.000846	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000121	0.000827	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00012	0.000817	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000119	0.000815	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000118	0.000803	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000118	0.000803	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000116	0.000794	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000792	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000115	0.000787	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000114	0.000779	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000113	0.000771	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000112	0.000767	CbGpPWpGaD
Sunitinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000111	0.000761	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000111	0.00076	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000109	0.000744	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000108	0.000739	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000108	0.000738	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.000107	0.000734	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000106	0.000724	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000106	0.000722	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000105	0.000719	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000105	0.000719	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000104	0.000711	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000103	0.000701	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000102	0.000696	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000101	0.000693	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000101	0.00069	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000101	0.000687	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—MET—Gilles de la Tourette syndrome	9.97e-05	0.000681	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.94e-05	0.00068	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—MET—Gilles de la Tourette syndrome	9.91e-05	0.000678	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.89e-05	0.000676	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.89e-05	0.000676	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.84e-05	0.000673	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.81e-05	0.000671	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.75e-05	0.000666	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.6e-05	0.000656	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.56e-05	0.000653	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.52e-05	0.000651	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—MET—Gilles de la Tourette syndrome	9.47e-05	0.000648	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.46e-05	0.000647	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.45e-05	0.000646	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.45e-05	0.000646	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.45e-05	0.000646	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.41e-05	0.000643	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.38e-05	0.000641	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.21e-05	0.00063	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.21e-05	0.00063	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.18e-05	0.000627	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.18e-05	0.000627	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.17e-05	0.000627	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	8.94e-05	0.000611	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.94e-05	0.000611	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.87e-05	0.000607	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.84e-05	0.000604	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.82e-05	0.000603	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.77e-05	0.000599	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.55e-05	0.000584	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.55e-05	0.000584	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.54e-05	0.000584	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.33e-05	0.000569	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	8.1e-05	0.000554	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	8e-05	0.000547	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	7.9e-05	0.00054	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7.76e-05	0.000531	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.59e-05	0.000519	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.57e-05	0.000518	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.36e-05	0.000503	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7.36e-05	0.000503	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.27e-05	0.000497	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	7.23e-05	0.000494	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7.15e-05	0.000489	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.14e-05	0.000488	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.14e-05	0.000488	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.1e-05	0.000486	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7.06e-05	0.000483	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.04e-05	0.000481	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.93e-05	0.000474	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.93e-05	0.000474	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.86e-05	0.000469	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.78e-05	0.000463	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.76e-05	0.000462	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.69e-05	0.000457	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.66e-05	0.000455	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.59e-05	0.00045	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.58e-05	0.00045	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.58e-05	0.00045	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.56e-05	0.000449	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.46e-05	0.000442	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.46e-05	0.000442	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.45e-05	0.000441	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.26e-05	0.000428	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.24e-05	0.000427	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.21e-05	0.000425	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.17e-05	0.000422	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.13e-05	0.000419	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.11e-05	0.000418	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.09e-05	0.000416	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.06e-05	0.000414	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.02e-05	0.000411	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.99e-05	0.000409	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.99e-05	0.000409	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.98e-05	0.000409	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.91e-05	0.000404	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.87e-05	0.000401	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.84e-05	0.000399	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.83e-05	0.000399	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.7e-05	0.00039	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.67e-05	0.000388	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.64e-05	0.000386	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.58e-05	0.000381	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.51e-05	0.000377	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.42e-05	0.00037	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.31e-05	0.000363	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.28e-05	0.000361	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.07e-05	0.000346	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.05e-05	0.000345	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	4.99e-05	0.000341	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.8e-05	0.000328	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.66e-05	0.000319	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.61e-05	0.000315	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.52e-05	0.000309	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.52e-05	0.000309	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.29e-05	0.000293	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.28e-05	0.000293	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.95e-05	0.00027	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.86e-05	0.000264	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.72e-05	0.000254	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.7e-05	0.000253	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.53e-05	0.000242	CbGpPWpGaD
